Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001783904-19-000001
Filing Date
2019-08-08
Accepted
2019-08-07 19:28:22
Documents
1
Effectiveness Date
2019-08-08
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 4746
  Complete submission text file 0001783904-19-000001.txt   5769
Mailing Address 262 S VAN PELT ST. PHILADELPHIA PA 19103
Business Address 262 S VAN PELT ST. PHILADELPHIA PA 19103 (206) 9494956
Trevarx Biomedical, Inc. (Filer) CIK: 0001783904 (see all company filings)

EIN.: 814441936 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-346047 | Film No.: 191007091